The US Food and Drug Administration (FDA) has approved a once-daily treatment with netarsudil and latanoprost ophthalmic solution (Rocklatan, Aerie Pharmaceuticals) to decrease elevated intraocular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback